• Home
  • About
    • About Us
    • Reimbursement Strategies
    • Appeals & Prior Auth.
    • Field Reimbursement
    • Health Policy
    • Durable Medical Equipment
    • Health Economics
    • Market Access
  • Leadership
  • Resources
  • Contact
  • More
    • Home
    • About
      • About Us
      • Reimbursement Strategies
      • Appeals & Prior Auth.
      • Field Reimbursement
      • Health Policy
      • Durable Medical Equipment
      • Health Economics
      • Market Access
    • Leadership
    • Resources
    • Contact
  • Home
  • About
    • About Us
    • Reimbursement Strategies
    • Appeals & Prior Auth.
    • Field Reimbursement
    • Health Policy
    • Durable Medical Equipment
    • Health Economics
    • Market Access
  • Leadership
  • Resources
  • Contact

Our Team

Chris Hanna, MBA

CEO – Walnut Hill Medical 

20 Years of Medical Device Commercialization Experience


Chris Hanna is the founder and CEO of Walnut Hill Medical. Walnut Hill Medical is a medical device professional services organization and a proven leader in healthcare policy.


With 20+ years of significant commercial and health policy leadership, He has commercialized multiple Class II and III external and active implantable neurostimulation devices.


He developed the commercial, operational infrastructure, health policy, reimbursement, and prior authorization strategies for Spark Biomedical, an auricular transcutaneous stimulator treating opioid withdrawal.


Prior to Spark Biomedical, He was a company founder and principal commercial leader at Nuvectra Medical, a spinal cord stimulation company, where he effectively built the business’ operational infrastructure, reimbursement, and prior authorization teams.


Before joining Nuvectra, He was the Director of Health Policy and Reimbursement at St. Jude Neuromodulation, leading a team of 25 case managers that processed over 22,000 prior authorizations annually for spinal cord stimulators. Additionally, he oversaw the Field Reimbursement team that educated 1,000+ customers on proper procedure billing and coding. He successfully led St. Jude’s Congressional lobbying efforts in Washington, DC, in removing the medical device tax from the Affordable Care Act.


His expertise and opinions on commercial and health policy are nationally recognized and respected. He is a former Adjunct Professor of US Health Policy at Southern Methodist University, where he earned his MBA. He received his Bachelor of Finance degree from Clemson University.

Start Your Voyage

Get in Touch

Chris Jordan

President – Walnut Hill Medical


Chris Jordan brings over 20 years of expertise in the medical device industry to his role

as President of Walnut Hill Medical. Chris has leadership experience driving sustained

and profitable growth across a diverse array of device companies, ranging from startups

to global leaders.


Chris began his career in the pain management sector with Neuro Resource Group,

where he developed proficiency in clinical knowledge and sales. He then joined St. Jude

Medical, where he advanced through increasingly senior roles in Healthcare

Economics, Corporate Accounts, Health Policy, and Enterprise Accounts. Following

Abbott's acquisition of St. Jude Medical, Chris continued his successful trajectory,

ultimately leading the $500 million Cardiology Enterprise Accounts Area. In this role, he

played a pivotal part in formulating and executing regional and national strategies for

long-term growth.


Passionate about building high-performing teams and fostering a winning culture, Chris

is dedicated to creating environments where innovation thrives, and individuals excel.

He has built a reputation for leading successful teams, driving innovation, and

effectively introducing new technologies and therapies to the market.


Chris earned his BBA in Marketing from the University of North Texas and his MS in

Healthcare Administration from the University of Texas at Arlington.

Start Your Voyage

Get in Touch

Kathy O'Neill, MBA

Director, Health Policy & Reimbursement


Kathy has been working in the medical device industry for more than 20 years. Her

years of experience and leadership continue to drive her work as a consultant to

medical device companies today.


As Senior Manager of Healthcare Economics for AngioDynamics, Inc., she developed

the AMA/CPT coding submission for a unique, critical care vascular device. She also

created the reimbursement strategy and infrastructure for the Vascular Interventions

Division.


Prior to that, Kathy was Senior Manager of Reimbursement, Health Policy & Prior

Authorization for Nuvectra Medical, where she worked with leadership and external

stakeholders to affect both government and commercial health policy in the US

neuromodulation market.


Kathy also spent 10 years working for Medtronic, Inc. in the Cardiac Rhythm

Management, then Neuromodulation Division. As Senior Manager, Health Economics,

she was the field reimbursement liaison for 45 sales representatives in 7 states,

regularly providing hospitals, physicians and facilities with economics and policy

analysis and coding, billing and reimbursement education. During her tenure, she

educated over 100 physicians, residents and fellows on reimbursement for

neuromodulation therapies.


Kathy spent 6 years working in advanced wound management, most notably with

Osiris Therapeutics, Inc. and Smith & Nephew, Inc., obtaining government and

commercial coverage, ensuring appropriate coding and reimbursement for novel

biologics considered medical devices. She started her medical device journey working

in dialysis care management for 5 years.


Kathy has an MBA in Health & Medical Services Administration from Widener University

and is an AAPC-Certified Outpatient Coder (COC).


Publication: O'Neill K. Spinal Cord Stimulation Leads: A Coding Perspective. AAPC

Healthcare Business Monthly July 2019, pp. 44-45. URL:

https://www.aapc.com/blog/47629-spinal-cord-stimulation-leads-a-coding-perspective/

Start Your Voyage

Get in Touch

Grace Cuillier

Director of Strategy


Grace earned a BS in microbiology at Washington State University where she studied

the innate immune response to West Nile Virus. She later obtained Master of Microbial

Biotechnology and MBA degrees from North Carolina State University where she

focused heavily on entrepreneurship and the challenges associated with bringing new

technologies to market. She worked closely with the technology transfer office and

cutting-edge innovations.


Grace has worked with a number of innovative companies in the biotechnology space

including United Therapeutics and Grifols. During her tenure at United Therapeutics,

she was a member of both the marketing and medical affairs teams where she helped

implement their patient education program in rare diseases and contributed to the

presentation of new clinical data. At Grifols she was heavily involved with sales

analytics with the immunology and neurology therapy teams.


She then focused on supporting innovation for multiple technologies and moved to

Proxima Clinical Research where she was a member of the business development and

regulatory affairs teams. She specialized in assisting emerging medtech companies

navigate the nuanced pathways to obtain regulatory approval.


At Walnut Hill Medical, she has built on her cross-disciplinary background to guide

medtech companies through the reimbursement, prior authorization, and DME

processes. Grace is committed to the success of biotech and medtech companies and

is ready to help innovators and founders navigate the “valley of death” from ideation to

commercialization.

Start Your Voyage

Get in Touch

Daniela Ordiway

Director, Prior Authorization & Appeals


With over a decade of experience in healthcare SaaS integration and customer success, Daniela has dedicated her career to help providers and patients access cutting-edge technology, impacting over 10 million patient lives.
 

After earning a BS in Kinesiology & Pre-Health, Daniela began her career working in Emergency Rooms and Pain Management Clinics nationwide. She then transitioned to innovative start-ups, addressing challenges in data accessibility and interoperability across disparate health systems and ensuring operational excellence in fast-growing organizations. At Walnut Hill Medical, Daniela now leverages her cross-functional expertise to guide medtech companies through prior authorization and DME processes, focusing on scalability and partnership. 

Start Your Voyage

Get in Touch
  • Home
  • About Us
  • Leadership
  • Resources
  • Contact
  • Privacy

Walnut Hill Medical

Copyright © 2025 Walnut Hill Medical - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept